In contrast, blockade of Y1R signaling with BIBP 3226 reversed these protective effects of NPY on AKI by largely increasing tubular necrosis and serum levels of creatinine in a dose-dependent manner (Figure 7a, b). The gene discussed is NPY; the disease is acute kidney injury.